Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Adenosine-diphosphate (ADP) Receptor Antagonists for the Prevention of Cardiovascular Disease in Type 2 Diabetes Mellitus: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438774/all/. Accessed 04 May 2024.
Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438774/all/. Accessed May 4, 2024.
Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438774/all/
Adenosine-diphosphate (ADP) Receptor Antagonists for the Prevention of Cardiovascular Disease in Type 2 Diabetes Mellitus: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 May 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438774/all/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus: Cochrane systematic review
ID - 438774
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438774/all/
DB - Evidence Central
DP - Unbound Medicine
ER -